GOLDMAN SACHS GROUP INC - THIRD HARMONIC BIO INC ownership

THIRD HARMONIC BIO INC's ticker is and the CUSIP is 88427A107. A total of 49 filers reported holding THIRD HARMONIC BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of THIRD HARMONIC BIO INC
ValueSharesWeighting
Q2 2024$472,056
-26.3%
36,312
-46.5%
0.00%
Q1 2024$640,816
+260.1%
67,883
+318.5%
0.00%
Q4 2023$177,955
+124.8%
16,222
-1.4%
0.00%
Q2 2023$79,173
+7557.0%
16,460
-69.8%
0.00%
Q3 2022$1,03454,5000.00%
Other shareholders
THIRD HARMONIC BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 10,907,859$52,466,8026.53%
Stonepine Capital Management, LLC 2,793,149$13,435,0474.85%
TANG CAPITAL MANAGEMENT LLC 1,800,000$8,658,0001.28%
BVF INC/IL 4,365,933$21,000,1380.58%
COMMODORE CAPITAL LP 993,294$4,777,7440.54%
Orbimed Advisors 5,779,071$27,797,3320.50%
Bain Capital Life Sciences Investors, LLC 640,631$3,081,4350.32%
EcoR1 Capital, LLC 2,088,780$10,047,0320.25%
GENERAL ATLANTIC, L.P. 2,958,762$14,231,6450.22%
Boxer Capital, LLC 570,417$2,7440.13%
View complete list of THIRD HARMONIC BIO INC shareholders